Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Icosavax, Inc. (ICVX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "Icosavax Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
08/08/2023 8-K Investor presentation
Docs: "Slide Presentation",
"Slide Presentation"
07/31/2023 144 Form 144 - Report of proposed sale of securities:
07/31/2023 144 Form 144 - Report of proposed sale of securities:
07/25/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/30/2023 SC 13D/A RA CAPITAL MANAGEMENT, L.P. reports a 12.5% stake in Icosavax, Inc.
05/23/2023 144 Form 144 - Report of proposed sale of securities:
05/23/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Opinion of Latham & Watkins LLP",
"Form of Securities Purchase Agreement"
05/23/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Quarterly results
Docs: "Icosavax Reports First Quarter 2023 Financial Results and Provides Corporate Update"
04/19/2023 ARS Form ARS - Annual Report to Security Holders:
04/19/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/19/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
02/14/2023 5 Russo Thomas Joseph (CFO) has filed a Form 5 on Icosavax, Inc.
02/14/2023 5 Kanesa-thasan Niranjan (Chief Medical Officer) has filed a Form 5 on Icosavax, Inc.
02/14/2023 5 Holtzman Douglas (Chief Scientific Officer) has filed a Form 5 on Icosavax, Inc.
02/14/2023 5 Cearley Cassia (Chief Business Officer) has filed a Form 5 on Icosavax, Inc.
02/14/2023 SC 13G/A NanoDimension III, L.P. reports a 3.2% stake in Icosavax, Inc.
02/09/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/10/2023 SC 13G T. Rowe Price Investment Management, Inc. reports a 11.2% stake in ICOSAVAX INC
01/10/2023 SC 13G FMR LLC reports a 12.2% stake in ICOSAVAX INC
12/21/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/13/2022 8-K Quarterly results
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/14/2022 8-K Quarterly results
Docs: "Icosavax Reports Third Quarter Financial Results and Provides Corporate Update"
08/30/2022 EFFECT Form EFFECT - Notice of Effectiveness:
08/15/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/15/2022 8-K Quarterly results
06/28/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy